Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

JediGreen Jun. 6 at 5:06 AM

$BCTX Never seen anything quite like it . Every thing is down. Major Indexes, oil, gold, silver, crypto. F the elites and the new world order. The grait awakening. Globalist will fail.

0 · Reply

Kings124566 Jun. 5 at 9:52 PM

$BCTX Nooooo!!!!

0 · Reply

TopCharts Jun. 5 at 8:14 PM

$BCTX I would expect another offering later this year whether or not it comes after Ph3 data release is question.

0 · Reply

ZacksResearch Jun. 5 at 5:37 PM

$BCTX just raised fresh capital — what does it mean for the next phase? 👀 BriaCell closed a best-efforts offering of 1,449,300 common shares at $3.25 per share, generating approximately $4.7 million in gross proceeds. 💰 The company plans to use the net proceeds for working capital, general corporate purposes, and advancing its business objectives. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38325&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38325

0 · Reply

2maligators Jun. 5 at 4:06 PM

$BCTX How are we gonna stay over $3 if we’re not expecting the big news til later this year? …

0 · Reply

rp6577 Jun. 5 at 3:33 PM

$BCTX added

0 · Reply

Blockybuster Jun. 5 at 3:08 PM

hold $BCTX and load up BFRI its heavily underpriced at marketcap of 12million while nearing FDA Decision in September this could triple or more even before potential approval.Best Luck

1 · Reply

Ares77manoe Jun. 5 at 2:18 PM

$BCTX adding

1 · Reply

Kirubin Jun. 5 at 1:15 PM

$BCTX $2 s here they come!

0 · Reply

shonv Jun. 4 at 5:39 PM

$BCTX we need ph3 update

4 · Reply

BriaCell Therapeutics Announces Closing of Offering

Mon, 01 Jun 2026 07:30:00 -0400 - 4 days ago

BriaCell Presents Positive Clinical Data at ASCO 2026

Sun, 31 May 2026 19:59:00 -0400 - 5 days ago

BriaCell Therapeutics Announces Pricing of Offering

2026-05-26T14:43:01.000Z - 10 days ago

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

2026-05-26T13:05:39.000Z - 10 days ago

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

Tue, 26 May 2026 07:30:00 -0400 - 10 days ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-05-22T13:27:19.000Z - 14 days ago

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

2026-05-22T11:49:02.000Z - 14 days ago

BriaCell announces data from Bria-IMT at ASCO 2026

Fri, 22 May 2026 07:30:00 -0400 - 14 days ago

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Fri, 15 May 2026 07:30:00 -0400 - 21 days ago

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

2026-05-14T15:31:53.000Z - 22 days ago

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

Thu, 14 May 2026 07:30:00 -0400 - 22 days ago

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

2026-05-13T16:39:28.000Z - 23 days ago

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

2026-05-13T14:41:55.000Z - 23 days ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

Wed, 13 May 2026 07:30:00 -0400 - 23 days ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Tue, 12 May 2026 07:30:00 -0400 - 24 days ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Thu, 07 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

2026-05-07T04:03:56.000Z - 4 weeks ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

Wed, 06 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Mon, 27 Apr 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

2026-04-21T13:28:43.000Z - 6 weeks ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T11:54:23.000Z - 6 weeks ago

BriaCell presents anti-cancer activity of Bria-OTS

Tue, 21 Apr 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

2026-04-20T13:32:04.000Z - 6 weeks ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T11:41:56.000Z - 6 weeks ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

Mon, 20 Apr 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Tue, 31 Mar 2026 16:05:00 -0400 - 2 months ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

2026-03-18T13:30:56.000Z - 2 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T11:42:55.000Z - 2 months ago

BriaCell to present four posters at the 2026 AACR

Wed, 18 Mar 2026 07:30:00 -0400 - 2 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Tue, 10 Mar 2026 07:30:00 -0400 - 3 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 3 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

2026-02-18T22:51:30.000Z - 3 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:35:25.000Z - 3 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

Wed, 18 Feb 2026 17:30:00 -0500 - 3 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

2026-02-17T12:40:59.000Z - 3 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

Tue, 17 Feb 2026 07:30:00 -0500 - 3 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-01-28T13:30:56.000Z - 4 months ago

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

2026-01-28T12:40:40.000Z - 4 months ago

BriaCell says patient images show regression, resolution of metastsized tumors

Wed, 28 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

2026-01-27T13:32:37.000Z - 4 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T12:41:04.000Z - 4 months ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

Tue, 27 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

2026-01-19T16:00:45.000Z - 4 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-16T13:58:57.000Z - 5 months ago

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

Thu, 15 Jan 2026 16:05:00 -0500 - 5 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

2026-01-14T11:36:30.000Z - 5 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:19:44.000Z - 5 months ago

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

2026-01-14T10:55:53.000Z - 5 months ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T06:56:44.000Z - 5 months ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

Jan 13, 2026, 9:00 PM EST - 5 months ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

2026-01-13T14:41:11.000Z - 5 months ago

BriaCell Therapeutics trading resumes

2026-01-13T14:35:29.000Z - 5 months ago

BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T12:35:49.000Z - 5 months ago

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

Jan 13, 2026, 7:30 AM EST - 5 months ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Dec 18, 2025, 7:30 AM EST - 6 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

2025-12-10T12:41:29.000Z - 6 months ago

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

Dec 10, 2025, 7:30 AM EST - 6 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

2025-12-09T12:35:35.000Z - 6 months ago

BriaCell announces Phase 3 patient enrollment on track for 1H26 data readout

Dec 9, 2025, 7:30 AM EST - 6 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

2025-12-02T12:36:29.000Z - 6 months ago

BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025

Dec 2, 2025, 7:30 AM EST - 6 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 6 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

2025-11-20T12:40:35.000Z - 7 months ago

BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics

Nov 20, 2025, 7:30 AM EST - 7 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 7 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 7, 2025, 7:30 AM EST - 7 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 7 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Oct 21, 2025, 7:50 AM EDT - 8 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 8 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 10 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 10 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 10 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 10 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 11 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 11 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 11 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 11 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

JediGreen Jun. 6 at 5:06 AM

$BCTX Never seen anything quite like it . Every thing is down. Major Indexes, oil, gold, silver, crypto. F the elites and the new world order. The grait awakening. Globalist will fail.

0 · Reply

Kings124566 Jun. 5 at 9:52 PM

$BCTX Nooooo!!!!

0 · Reply

TopCharts Jun. 5 at 8:14 PM

$BCTX I would expect another offering later this year whether or not it comes after Ph3 data release is question.

0 · Reply

ZacksResearch Jun. 5 at 5:37 PM

0 · Reply

2maligators Jun. 5 at 4:06 PM

$BCTX How are we gonna stay over $3 if we’re not expecting the big news til later this year? …

0 · Reply

rp6577 Jun. 5 at 3:33 PM

$BCTX added

0 · Reply

Blockybuster Jun. 5 at 3:08 PM

hold $BCTX and load up BFRI its heavily underpriced at marketcap of 12million while nearing FDA Decision in September this could triple or more even before potential approval.Best Luck

1 · Reply

Ares77manoe Jun. 5 at 2:18 PM

$BCTX adding

1 · Reply

Kirubin Jun. 5 at 1:15 PM

$BCTX $2 s here they come!

0 · Reply

shonv Jun. 4 at 5:39 PM

$BCTX we need ph3 update

4 · Reply

Kings124566 Jun. 4 at 2:34 PM

$BCTX Wouldn’t be surprised if the big boys are dumping the warrants precisely because Retail is buying them.

2 · Reply

supplySHOCK Jun. 4 at 10:27 AM

$WNW $ARBK $BCTX $CMCT form

0 · Reply

JediGreen Jun. 4 at 6:41 AM

$BCTX what could briacell therapeutics be revalued at if phase 3 is good - Google Search https://www.google.com/search?q=what+could+briacell+therapeutics+be+revalued+at+if+phase+3+is+good&sa=X&sca_esv=a82350b6429375af&source=lnms&fbs=ADc_l-ZMtfrlQ0SU6L2D0-D344flsprUi5NYvvJVflrdjdmmndzc87yxCU-u2_IZZ9ETkTM_HbA3DoDZGnoXz0Rfyvue0BQgoBLD40wOylysF54ifkKBxD_ZqR729VB49_Xd3vdoAuxo2gSVRmbXhMMCCfqlh26UzktfjQf0kKA6d3NGvs6c9Fyi2YfXghWQqA8nzCD9cjqptq6D8NW8kWHnijiSzPux_cv3d13UkeLuw17_WMCZR7s&aep=1&ntc=1&ved=2ahUKEwjpwLr__OyUAxWonokEHVJXMxwQ2J8OegQIDhAE&mstk=AUtExfD7X6F4W5vGyGILbIWeNKgb_bAOhPre62_4qoNFxw_EVjAMhVA3ofEM7HnDd4hY91uC9-octO_tprIHiIcte7gYpffXHRtDziLOs9l7MpzZ9o7vC2VXign4seX2Bzc9A6LkrVbikyt7UaDX-xrljoTuyB_1ANIiCQ0&csuir=1&udm=50&biw=430&bih=721&dpr=3

0 · Reply

JediGreen Jun. 4 at 6:17 AM

$BCTX

0 · Reply

JediGreen Jun. 4 at 6:17 AM

$BCTX what's the typical market cap for a small pharmaceutical company - Google Search https://www.google.com/search?q=whats+the+tipical+marcat+cap+for+a+small+pharmaceutical+company&sca_esv=a82350b6429375af&source=hp&ei=5hchasHoK67vmLQPh9WYuA0&biw=430&bih=721&oq=&gs_lp=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&sclient=mobile-gws-wiz-hp#lfId=ChxjMe

0 · Reply

rp6577 Jun. 3 at 6:15 PM

$BCTX it could get crazy here

0 · Reply

EscapePlan Jun. 3 at 3:56 PM

$BCTX Well, that's me done. 50,000 after picking 5,000 at 0.9 today and then 15,000 at less than 0.82. Still less than 10% of my portfolio but a huge bet for me.

1 · Reply

EscapePlan Jun. 3 at 3:51 PM

$BCTX "The share quantity entered for this order is greater than the maximum allowed. Please review your order or contact a Fidelity representative at 1-800-544-6666 for additional information."

0 · Reply

EscapePlan Jun. 3 at 3:50 PM

$BCTX Trying to buy more - but being told that i've exceeded the maximum amount you can buy!

0 · Reply

EscapePlan Jun. 3 at 3:47 PM

$BCTX 5000 more just now at $0.82. 40,000 total now

0 · Reply

EscapePlan Jun. 3 at 1:55 PM

$BCTX 5000 more warrants for me this morning at 90 cents... I think i'll look at buying10k more to get me up to 50,000 in the next couple of weeks. If i can get them under 90c i will. Maybe it will all go sour, but we have until 2031 for this company to become more valuable than $23M - got to think that will happen, but you never know. Good luck all longs

0 · Reply

typevoid Jun. 3 at 11:13 AM

$BCTX 8-K: Raised $4.71M by selling 1.45M shares at $3.25. Provides immediate liquidity but results in equity dilution. Warrants issued to agent at $4.0625. check out the filing: http://s.founcha.com/OmSY6

1 · Reply

Market Cap	24.00M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	178,200
Avg Vol	213,500
Day's Range	N/A - N/A
Shares Out	7.25M
Stochastic %K	6%
Beta	1.21
Analysts	Strong Buy
Price Target	$40.00